WinstonWınston
Back
BIO-key International logo

BIO-key International

BKYI
37
Information Technology Services · Technology
Price
$3.07
-0.03 (-0.97%)
Market Cap
$3.3M
Exchange
NASDAQ
Winston Score
37
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+1435.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 43K (2021) → 665K (2025)

Winston Score History

The full picture

BIO-key International makes software and hardware that uses fingerprints to verify who someone is before they can log into a computer system or access sensitive data. Its main products include fingerprint scanners and identity management software sold to businesses, hospitals, schools, and government agencies. The company operates in the biometric identity and cybersecurity industry, competing against much larger players like Microsoft and Okta.

BIO-key earns money by selling its fingerprint reader devices and charging software licenses or subscription fees for its identity platform. It operates primarily in the United States but has pursued some international customers, particularly in Africa and the Middle East. The company is very small, with a market cap near zero, and has struggled to reach profitability, as its deeply negative operating margin shows. The biggest risk it faces is burning through cash before it can scale its customer base enough to cover costs.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.1% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+72.1% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$3M/ year

Flat (+4% vs prior year)

42.8% of revenue

2.9x the sector average (15%)

Steady R&D investment year-over-year

Insider Activity

11.3%ownership

Insiders own a meaningful stake in the company

Cash Runway

~14 months

$4M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Adequate runway but may need to raise capital within 2 years

Growth context

BIO-key International is growing revenue at 13% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
87.2%
Premium pricing power — 87.2% gross margin
Profit after running costs
Operating Margin
-27.6%
Losing money on operations — -27.6%
Return on the money invested
ROCE
-71.0%
Weak — -71.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-0.8%
Shrinking sales (-0.8% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-60.6%
Burning cash (-60.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.03
Conservative — low debt load (0.03)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial